Added to YB: 2025-11-19
Pitch date: 2025-11-17
HOOK [neutral]
HOOKIPA Pharma Inc.
+0.81%
current return
Author Info
Liquidation stocks is focused on liquidation and wind downs of listed stocks. I cover USA, Canada, UK, Europe, Australia, NZL, Japan, Hong Kong and other countries. Sign up for the newsletter.
Company Info
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform.
Market Cap
$11.2M
Pitch Price
$0.86
Price Target
1.28 (+47%)
Dividend
N/A
EV/EBITDA
0.40
P/E
-0.15
EV/Sales
-3.05
Sector
Biotechnology
Category
special_situation
Liquidations Watchlist - Hookipa Pharma Inc
HOOK (liquidation): Biotech liquidating after failed merger, est. $1.28-$1.72 distribution vs current price. Delaware law requires 3yr hold period for claims. Key risk: potential liabilities emerging during 3.5yr timeframe. NAV-based play for patient investors willing to wait.
Read full article (1 min)